Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Kubota Pharmaceutical Holdings Co., Ltd. (4596)
Market Closed
10 Aug, 06:00
JPX
All
(2)
JP
(1)
MY
(1)
JPX
Primary
XKLS
¥
65.
00
+2
+3.1746%
¥
3.31B
Market Cap
-
P/E Ratio
-
Div Yield
1.73M
Volume
-
Eps
¥
63
Previous Close
Watching
Watch
Add Transaction
Day Range
61
66
Year Range
41
350
Want to track
4596
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Earnings
Statistics
Historical Data
Kubota Pharmaceutical Holdings Co., Ltd. (4596) Statistics
Valuation metrics
Market Cap
3.31B
Enterprise value
2.25B
Trailing P/E (ttm)
-6.92
Forward P/E
-
PEG ratio
-0.07
Price/Sales (ttm)
214.08
Price/Book (mrq)
4.56
Enterprise Value/Revenue
119.92
Enterprise Value/EBITDA
-2.43
Overview
Shares outstanding
115.4M
Float
57.94M
Shares short
-
% Held by insiders
0.41%
% Held by institutions
0.05%
Average volume (10 days)
1.6M
Average volume (90 days)
3.03M
Price summary
52-Week low
41
52-Week high
350
Beta
1.94
50-Day moving average
64.63
200-Day moving average
96.01
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2025
Profitability
Profit margin
-38.85%
Operating margin
-49.41%
Operational effectiveness
Return on assets
-0.39%
Return on equity
-0.46%
Income Statement
Revenue (ttm)
17.75M
Revenue per share (ttm)
0.15
Quarterly revenue growth (yoy)
-0.45%
Gross profit (ttm)
62.63M
EBITDA
-793M
Net income to common (ttm)
-729.42M
Diluted EPS (ttm)
-6.02
Quarterly earnings growth (yoy)
-0.61%
Balance Sheet
Total cash (mrq)
1.79B
Total cash per share (mrq)
14.75
Total debt (mrq)
18M
Total Debt/Equity (mrq)
0.01
Current ratio (mrq)
9.87%
Book value per share (mrq)
13.82
Cash Flow
Cash flow statement
-601.57M
Levered free cash flow (LFCF)
-676.25M